CYP4V2 p.Ser347Pro
c.1039T>C · VCV4009034
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8853 | likely pathogenic |
|---|---|---|
| REVEL | 0.304 | indeterminate |
| SaProt | LLR -10.40 | damaging |
| ⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.5 | GERP -0.091, phastCons 0.53 |
| Regional constraint | o/e 1.02 | unconstrained · MANE · 19 kb · p 0.64 · regional, not allelic |
| Overall | ||
| CADD | 22.2 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CYP4V2
- Protein
- p.Ser347Pro
- Coding
- c.1039T>C
- MANE Select
- NM_207352
- Type
- single nucleotide variant
- Location
- chr4:186205251 (GRCh38)
- Gene constraint
- LOEUF 1.126 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 91.05
Similar variants
- CYP4V2 p.Ser347Cys Uncertain significance ★ ⚠ same residue
- CYP4V2 p.Ala101Val Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Ala185Glu Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Ala25Thr Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Ala370Thr Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Ala456Gly Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Arg221His Uncertain significance ★★ ⚠ same condition
- CYP4V2 p.Asn104Asp Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cyp4v2-p-ser347pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown